34th Transcatheter Cardiovascular Therapeutics Annual Scientific Symposium (TCT 2022)

Boston, Massachusetts, US 16 September 2022 - 19 September 2022

Does cerebral embolic protection reduce stroke risk post-TAVR?

27 Oct 2022 bởi

The use of a cerebral embolic protection (CEP) device did not reduce the risk of periprocedural stroke in patients undergoing transcatheter aortic valve replacement (TAVR), according to results of the PROTECTED TAVR study presented at TCT 2022.

27 Oct 2022

Amphilimus- vs zotarolimus-eluting stents: Any preference in patients with diabetes?

20 Oct 2022 bởi

Updated results of the SUGAR* trial showed that using polymer-free amphilimus-eluting stents (AES) was not a superior option to durable-polymer zotarolimus-eluting stents (ZES) in patients with diabetes mellitus who required percutaneous coronary intervention (PCI).

20 Oct 2022

Rivaroxaban cuts radial artery occlusion rates

19 Oct 2022 bởi

Rivaroxaban reduces radial artery occlusion rate, without significantly increasing bleeds, in patients undergoing transradial coronary procedures in the RIVARAD study.

19 Oct 2022

Alirocumab prior to PCI lowers LDL-C

18 Oct 2022 bởi

Starting alirocumab early in the hospital prior to undergoing percutaneous coronary intervention (PCI) reduces LDL-cholesterol (LDL-C) in STEMI* patients already on high-statin therapy.

18 Oct 2022

Updated BEST results: No major difference between EES or CABG for multivessel disease

14 Oct 2022 bởi

In patients with multivessel coronary artery disease, the risk of any-cause death, myocardial infarction (MI), or target vessel revascularization (TVR) did not vary according to whether patients underwent percutaneous coronary intervention (PCI) with everolimus-eluting stents (EES) or coronary artery bypass graft (CABG), extended follow-up of the BEST* trial showed.

14 Oct 2022

PASCAL System augments treatment armamentarium for severe mitral regurgitation

06 Oct 2022 bởi

In the CLASP* IID trial, the PASCAL Transcatheter Valve Repair System demonstrated noninferiority to the MitraClip System for the treatment of severe symptomatic degenerative mitral regurgitation (DMR).

06 Oct 2022

Bashir catheter shows treatment potential for pulmonary embolism

05 Oct 2022 bởi

Pharmacomechanical catheter-directed thrombolysis (PM-CDT) using the Bashir endovascular catheter demonstrated potential for the treatment of intermediate-risk acute pulmonary embolism (PE), findings from the RESCUE* trial have shown.

05 Oct 2022

Renal denervation bounces back in 3-year follow-up study

29 Sep 2022 bởi

Following negative primary results, the final follow-up of the SYMPLICITY HTN-3 trial takes a turn for the better, demonstrating significant blood pressure (BP) reductions with renal denervation (RDN) in patients with uncontrolled hypertension (HTN).

29 Sep 2022